Stock Price Quote

GLENMARK PHARMACEUTICALS LTD.

NSE : GLENMARKBSE : 532296ISIN CODE : INE935A01035Industry : Pharmaceuticals & DrugsHouse : Glenmark
BSE640.85-2.8 (-0.44 %)
PREV CLOSE ( ) 643.65
OPEN PRICE ( ) 649.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 64509
TODAY'S LOW / HIGH ( )638.00 650.00
52 WK LOW / HIGH ( )387.25 658
NSE640.90-2.95 (-0.46 %)
PREV CLOSE( ) 643.85
OPEN PRICE ( ) 647.75
BID PRICE (QTY) 640.90 (1545)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1051668
TODAY'S LOW / HIGH( ) 638.00 649.05
52 WK LOW / HIGH ( )387.05 658.2
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 18-11 1977
Management Info
Glenn Saldanha - Chairman Glenn Saldanha - Managing Director
Registered Office

Address B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road, ,
Mumbai,
Maharashtra-400026

Phone

Email webmaster@glenmarkpharma.com

Website www.glenmarkpharma.com

Registrars Details
K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

15Jun Glenmark Pharmaceuticals informs about
Glenmark Pharmaceuticals has informed that it has attached media release..
15Jun Glenmark launches Tiotropium Bromide D
Glenmark Pharmaceuticals has launched bioequivalent version of Tiotropiu..
04Jun Glenmark Pharmaceuticals, Britannia In
Glenmark Pharmaceuticals has received final approval by the United State..
04Jun Glenmark gets USFDA’s nod for Theophyl
Glenmark Pharmaceuticals (Glenmark) has received final approval by the U..
04Jun Glenmark gains on getting USFDA’s nod
Glenmark Pharmaceuticals is currently trading at Rs. 619.35, up by 3.10..

Financials

in Millions
QTR Mar 21 ANNUAL 21
Net Profit3417.7516494.47
Gross Profit 3733.6 19437.57
Operating Profit 4728.6722865.78
Net Sales 18503.6975679.33

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  16452.15 (1.05%)
M.Cap ( in Cr)34959.67
Orchid Pharma (BSE)
peergroup  1347.95 (5.24%)
M.Cap ( in Cr)5501.85
Ajanta Pharma (BSE)
peergroup  1993.00 (2.80%)
M.Cap ( in Cr)17245.78
Bajaj Healthcare (BSE)
peergroup  711.90 (5.56%)
M.Cap ( in Cr)982.37
Themis Medicare (BSE)
peergroup  747.45 (5.12%)
M.Cap ( in Cr)687.20

Shareholding Pattern

PROMOTERS 46.63%
MUTUAL FUNDS/UTI 3.27%
NON-INSTITUTION 18.38%
FI/BANKS/INSURANCE 0.55%
GOVERNMENT 0%
FII 0%

About Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd. was incorporated in the year 1977. Its today's share price is 640.85. Its current market capitalisation stands at Rs 18082.75 Cr. In the latest quarter, company has reported Gross Sales of Rs. 67126.31 Cr and Total Income of Rs.73194.19 Cr. The company's management includes Dipankar Bhattacharjee, Harish Kuber, Saira Ramasastry, D R Mehta, B E Saldanha, Sridhar Gorthi, Bernard Munos, Brian W Tempest, Rajesh V Desai, VS Mani, Cherylann Pinto, Glenn Saldanha, Glenn Saldanha.

It is listed on the BSE with a BSE Code of 532296 , NSE with an NSE Symbol of GLENMARK and ISIN of INE935A01035. It's Registered office is at B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road, Mumbai-400026, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Arthur Andersen & Associates, Price Waterhouse, VK Bahri & Co, Walker Chandiok & Co LLP, Walker, Chandiok & Co, Walker, Chandiok & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)